 DETERMINE IF EITHER OF 2 DOSES OF STUDY DRUG GIVEN WITH A LOW-DOSE OF CYCLOPHOSPHAMIDE AFTER A COMPLETE OR PARTIAL RESPONSE TO A PLATINUM-BASED SECOND-LINE THERAPY IN WOMEN WITH RECURRENT OVARIAN CARCINOMA RESULTS IN A LONGER TIME TO PROGRESSION WHEN COMPARED TO THE FIRST TIME TO PROGRESSION.: 